Z-2732-2017 Class II Terminated
FDA device recall Z-2732-2017 was initiated by Nova Biomedical Corporation on Jun 19, 2017 and is designated Class II. Reason for recall: Software- scheduled A-QC analysis could initiate prior to a patient result being released by the operator and result in the pending patient result being overwritten with the A-QC test results. The recall status is terminated (terminated Aug 14, 2018). Affected quantity: 179 units (US) and 904 (OUS) Total 1083.
Recall details
- Product Type
- Devices
- Report Date
- Jul 19, 2017
- Initiation Date
- Jun 19, 2017
- Termination Date
- Aug 14, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 179 units (US) and 904 (OUS) Total 1083
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - US (Nationwide) Foreign: Albania Algeria Argentina Australia Austria Bangladesh Benin Bolivia Brazil Canada Chile China Colombia Costa Rica Czech Republic ECUADOR Egypt El Salvador Finland France Germany Ghana Greece Guatemala Guyana Honduras Hong Kong Hungary ICELAND India Iran Israel Italy Ivory Coast Japan Jordan Kenya Korea Latvia Macedonia Malaysia Mexico Nepal Netherlands Nigeria Pakistan Pakistan Palestine Peru Philippines Poland Puerto Rico Republic of Panama Republica Dominicana Russia Saudi Arabia Slovak Republic Slovenia South Africa Sri Lanka Switzerland Taiwan Thailand The Netherlands Trinidad,W.I. Tunisia Turkey UK Uruguay Vietnam
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2732-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Nova Biomedical Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.